(2013) compared women with ovarian cysts due due to endometriosis who took NAC with an untreated control group
Higher doses (90 mg and 120 mg) achieved up to 12.2% mean reduction from baseline (26.6 lbs) versus 1.3% (2.9 lbs) for placebo, with up to 97% of patients losing 5% of body weight
If youve started GLP-1 therapy and are feeling tired, dehydrated, or uncomfortable, IV therapy may offer the support you need
Future studies should focus on exploring their efficacy in different patient groups, evaluating their long-term efficacy and safety, and further refining treatment strategies to fully realize their therapeutic potential [86]
Topline results from a Phase 3b trial in the global STEP program demonstrated statistically significant and superior weight loss at 72 weeks with semaglutide 7.2 mg, compared with placebo, irrespective of treatment adherence
Like semaglutide products, tirzepatide is used to control blood sugar levels, and is administered via a weekly injection